Menu
Recruiting NCT07210658

Acceptability, Gastrointestinal Tolerance, Compliance and Palatability Study.

No phase Interventional Paediatrics

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Oral nutritional supplementation.
Who it may be relevant to
Registry conditions: Paediatrics. Basic parameters: 1 year — 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Acceptability (Including Gastrointestinal Tolerance, Compliance and Palatability) of a Paediatric Oral Nutritional Supplement Containing Food Blends.

Overview

Acceptability, compliance and palatability study.

Detailed description

Acceptability (including gastrointestinal tolerance, compliance and palatability) of a paediatric oral nutritional supplement containing food blends.

Interventions

  • Dietary supplement Oral nutritional supplementation
    As directed by the HCP

Primary outcome measures

  • Gastrointestinal tolerance [Time frame: Days 1-7, and at day 14, 21 and 28]
Secondary outcome measures (1)
  • Formula intake in mLs [Time frame: 28 days]

Eligibility criteria

Inclusion criteria

  • Patients from 1-15 years requiring 1 or more oral nutritional supplement to replace current oral nutritional supplement as part of their dietary management for disease related malnutrition.
  • Patients well-established and stable on current nutritional support regimen.
  • Willingly given, written, informed consent from patient/caregiver.

Exclusion criteria

  • Unsafe swallow
  • Inability to comply with the study protocol, in the opinion of the investigator.
  • Under 1 years of age
  • Patients on total parenteral nutrition
  • Known food allergies, including any allergies to the ingredients
  • Patients with Chronic Kidney Disease (CKD) stage 3b (G3b), stage 4 (G4), stage 5 (G5) or hepatic impairment.
  • Participation in another interventional study within 2 weeks of this study.
  • Patients with known or suspected ileus or mechanical bowel obstruction

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United Kingdom · 1 center
  • Dietetics — Nottingham

Identifiers

NCT: NCT07210658 · ONS FB 001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗